Search

1 Results found

Articles companion-animals

13 April 2022

The aim of this study was to evaluate the safety and efficacy of cabergoline to control hypersomatotropism (HST) and diabetes mellitus (DM) in cats.

This was a prospective cohort study. Twenty-three cats with HST and concurrent DM were enrolled. Cats received a dose of 10 μg/kg cabergoline q48h PO for 6 months.

Like0

Dislike0

Page of 1 1

News of interest

Advancing the 3Rs: innovation, implementation, ethics and society

One Committed and Caring NC State Veterinary Student, So Many Choices

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Philanthropic Support and Specialized Surgery Saves Dog with Oral Tumor

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top